An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse modelChenwei Wang, Lin Chen, Jingyao Li et al.|Journal of Clinical Investigation|2024Cited by 6